Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2012
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium reportBrigitte C Widemann, Aerang Kim, Elizabeth Fox, et al.Pediatric Blood & Cancer|October 16, 2012
A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893Judy L Felgenhauer, Michael L Nieder, Mark D Krailo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
A phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a children's oncology group phase I consortium reportJulia Glade Bender, Susan M Blaney, Scott Borinstein, et al.European Journal of Cancer (Oxford, England : 1990)|December 6, 2011
Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG projectPaola Angelini, Wendy B London, Susan L Cohn, et al.Translational Oncology|August 2, 2011
Moving forward with metronomic chemotherapy: meeting report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric OncologyEddy Pasquier, Mark W Kieran, Jaroslav Sterba, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2011
Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group studySteven G Dubois, Suzanne Shusterman, Ashish M Ingle, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium ReportSarah E S Leary, Julie R Park, Joel M Reid, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade gliomaEric Bouffet, Regina Jakacki, Stewart Goldman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium reportJulia L Glade Bender, Alice Lee, Joel M Reid, et al.European Journal of Cancer (Oxford, England : 1990)|June 10, 2009
A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumoursSylvain Baruchel, Julia R Sharp, Ute Bartels, et al.Pageof 8